Disease-branding and drug-mongering: could pharmaceutical industry promotional practices result in tort liability?
Jason S
JS
Cetel
D000329:Advertising / Q000331:legislation & jurisprudence*; D003256:Community Participation; D003933:Diagnosis; D004194:Disease / Q000145:classification*; D017277:Drug Approval / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004358:Drug Therapy / Q000145:classification*; D049673:History, 20th Century; D006801:Humans; D007880:Legislation, Drug / Q000266:history; D016365:Liability, Legal; D008318:Malpractice / Q000331:legislation & jurisprudence; D040541:Marketing / Q000331:legislation & jurisprudence*; D010565:Persuasive Communication; D014481:United States